This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR modulators.

The chipmaker has overcome numerous obstacles to sell its AI chips in China.

Tesla's Terafab chip fab project launches March 21. Here's what the $20 billion facility means for TSLA stock, and the future of Optimus and FSD.

Williams-Sonoma shares surged after the San Francisco-based retailer reported better-than-expected earnings and boosted its dividend.

Three important — and potentially useful — things leap out of the latest BofA fund-manager survey.

Disney CEO Bob Chapek would hand over the baton to Josh D’Amaro. So how should investors play DIS stock now?

Lululemon says it's looking to sell more clothes at full price this year, as it works to shore up declining margins.

Alibaba is expected to deliver a solid quarter supported by sustained demand across its cloud computing and AI businesses.

The S&P 500 Index ($SPX ) (SPY ) today is down -0.55%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.82%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. March E-mini S&P futures (ESH26 ) are down -0.48%, and March E-mini Nasdaq fut

Cincinnati Financial Corporation stock has outperformed other property and casualty insurance stocks, and analysts remain fairly bullish about its prospects.

The market is underappreciating the growth potential for this chipmaker.

This clinical-stage biotech develops therapies for CML, NASH, and obesity.

As Expeditors has underperformed relative to the industrial sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Recent events are turning the energy sector on its head, but these stocks still offer safe dividend income.